YY2 Serves as a Novel Prognostic Biomarker Correlated with Immune Microenvironment and Glycolysis in Esophageal Carcinoma.

Curr Genomics · 2025 · PMC12606659 · PMID 41235100

Europe PMC DOI

hedged sentence

0.0592

closest p · 1.2× alpha

0.0592

boldest claim

The sentences

borderline significancep = 0.0592so close (0.05 < p ≤ 0.1)

Survival analysis indicated that individuals with altered YY2 demonstrated a trend towards poorer prognosis, with borderline significance ( p = 0.0592, Fig. 2C ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.